When: 3 – 6 September 2024
Where: Parsippany Hilton, Parsippany, New Jersey
Connect with Susan Lynch-Smith, who will be representing Douglas CDMO at this year’s event. Discover how we support biotechnology and pharmaceutical companies throughout the product development lifecycle.
With extensive experience in developing and manufacturing a variety of dosage forms, and deep specialist expertise in high-potency softgel and liquid formulations, we bring world-class knowledge and reputable high-quality standards to the table.
Learn more about the event here.
Susan Lynch-Smith, Head of Business Development, Douglas CDMO
Other posts you may be interested in...
Articles
Bespoke client solutions: A personalized approach as a privately owned CDMO
Douglas CDMO is making its mark in the pharmaceutical development industry with their flexible and personalized approaches to client needs.
Learn MoreArticles
Smart softgels: driving innovation in pharma
In the dynamic landscape of pharmaceuticals, one innovation has consistently pushed the boundaries of drug delivery: the softgel capsule.
Learn MoreCase Studies
Seizing market share pre-patent expiry: Navigating a paragraph IV ANDA submission
Douglas CDMO partnered with a US pharmaceutical firm to develop a cutting-edge generic isotretinoin softgel, overcoming regulatory and technical complexities, launching with remarkable success.
Learn More